🔥🐔 BizChicken 🐔🔥
Companies Similar to Leap Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Enliven Therapeutics, Inc.
small molecule kinase inhibitors
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule inhibitors for cancer treatment, including key products ELVN-001 and ELVN-002 under clinical trials.
About | About | Directors | About | Contact | Contact | Careers | Careers | Careers | Jobs | Careers | About | Vision/Values
Symbol: ELVN
Recent Price: $22.39
Industry: Biotechnology
CEO: Mr. Samuel S. Kintz M.B.A.
Sector: Healthcare
Employees: 52
Address: 6200 Lookout Road, Boulder, CO 80301
Phone: 720 647 8519
Leadership
- Sam Kintz, Co-founder, Chief Executive Officer, and Member of the Board of Directors
- Joe Lyssikatos, Co-founder, Chief Scientific Officer
- Anish Patel, Co-founder and Chief Operating Officer
- Helen Collins, Chief Medical Officer
- Ben Hohl, Chief Financial Officer and Head of Corporate Development
- Galya Blachman, Chief Legal Officer and Head of Business Development
- Rich A. Heyman, Chairman of the Board of Directors
- Rishi Gupta, Member of the Board of Directors
- Andy Phillips, Member of the Board of Directors
- Mika Kakefuda Derynck, Member of the Board of Directors
- Jake Bauer, Member of the Board of Directors
- Rahul Ballal, Member of the Board of Directors
- Lori Kunkel, Member of the Board of Directors
- Brian Druker, Scientific Advisor
- Kevin Koch, Scientific Advisor
Last updated: 2024-12-31
Candel Therapeutics, Inc.
CAN-2409, CAN-3110
Candel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing immunotherapies for cancer patients, with products like CAN-2409 and CAN-3110 in various clinical trial phases.
About | About | About | About | Contact | Careers | Careers | About | About | About | Careers | About
Symbol: CADL
Recent Price: $7.95
Industry: Biotechnology
CEO: Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.
Sector: Healthcare
Employees: 42
Address: 117 Kendrick Street, Needham, MA 02494
Phone: 617 916 5445
Last updated: 2024-12-31
Dianthus Therapeutics, Inc.
DNTH103
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on designing, developing, and delivering novel monoclonal antibodies for severe autoimmune and inflammatory diseases. Their lead product, DNTH103, is in phase 1 clinical trials.
Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | About
Symbol: DNTH
Recent Price: $21.50
Industry: Biotechnology
CEO: Mr. Marino Garcia M.B.A.
Sector: Healthcare
Employees: 53
Address: 7 Times Square, New York, NY 10036
Phone: 929-999-4055
Last updated: 2024-12-31
Pyxis Oncology, Inc.
PYX-106, PYX-102, PYX-201, PYX-202, PYX-203
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, focuses on developing therapies to treat various cancers through immune-oncology and antibody drug conjugate product candidates.
Symbol: PYXS
Recent Price: $1.56
Industry: Biotechnology
CEO: Dr. Lara S. Sullivan M.D., MBA
Sector: Healthcare
Employees: 55
Address: 35 Cambridgepark Drive, Cambridge, MA 02140
Phone: 617 221 9059
Last updated: 2024-12-31
Beam Therapeutics Inc.
precision genetic medicines
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States, with a focus on conditions such as sickle cell disease, beta thalassemia, and Glycogen Storage Disease Type Ia.
About | Contact | Careers | Careers | Careers | Careers | Jobs | Careers | About | About | About | Careers | About | Jobs | Careers
Symbol: BEAM
Recent Price: $25.28
Industry: Biotechnology
CEO: Mr. John M. Evans M.B.A.
Sector: Healthcare
Employees: 472
Address: 238 Main Street, Cambridge, MA 02142
Phone: 857 327 8775
Last updated: 2024-12-31
Bolt Biotherapeutics, Inc.
BDC-1001
Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing immuno-oncology agents that target tumor cells for immune system elimination.
Symbol: BOLT
Recent Price: $0.57
Industry: Biotechnology
CEO: Mr. William P. Quinn
Sector: Healthcare
Employees: 100
Address: 900 Chesapeake Drive, Redwood City, CA 94063
Phone: 650 665 9295
Last updated: 2024-12-31
Compass Therapeutics, Inc.
CTX-009, CTX-471, CTX-8371
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing antibody-based therapeutics to treat various human diseases. Their clinical stage products include investigational bispecific antibodies like CTX-009 and monoclonal antibodies such as CTX-471.
Symbol: CMPX
Recent Price: $1.48
Industry: Biotechnology
CEO: Dr. Thomas J. Schuetz M.D., Ph.D.
Sector: Healthcare
Employees: 32
Address: 80 Guest Street, Boston, MA 02135
Phone: 617 500 8099
Last updated: 2024-12-31
Day One Biopharmaceuticals, Inc.
DAY101
Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for genetically defined cancers. Their lead product candidate is DAY101, currently in Phase II clinical trials for pediatric patients with low-grade glioma.
Vision/Values | Leadership | About | Contact | About | Leadership | Leadership | Leadership | Leadership | Leadership | About | About
Symbol: DAWN
Recent Price: $12.58
Industry: Biotechnology
CEO: Dr. Jeremy Bender M.B.A., Ph.D.
Sector: Healthcare
Employees: 174
Address: 395 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 484 0899
Leadership
- Samuel Blackman, MD, PhD, Head of R&D
- Elly Barry, MD, Chief Medical Officer
- Jeremy Bender, PhD, MBA, Director
- Davy Chiodin, PharmD, Chief Development Officer
- Adam Dubow, General Counsel
- Lauren Merendino, MBA, Chief Commercial Officer
- John Stubenrauch, Chief Technology Officer
- Jaa Roberson, Chief People Officer
- Charles N. York II, MBA, Chief Operating and Financial Officer
- Garry Nicholson, MBA, Chair
- Habib Dable, Director
- Scott Garland, Director
- Michael Gladstone, Director
- William Grossman, MD, PhD, Director
- Natalie Holles, Director
- John A. Josey, PhD, MBA, Director
- Saira Ramasastry, MS, MPhil, Director
Last updated: 2024-12-31
4D Molecular Therapeutics, Inc.
4D-125, 4D-110, 4D-310, 4D-150, 4D-710
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company developing product candidates using adeno-associated virus vectors, focusing on ophthalmology, cardiology, and pulmonology.
About | About | Contact | News | News | News | Careers | Careers | About | DEI | Careers | Leadership | Careers | Careers
Symbol: FDMT
Recent Price: $5.30
Industry: Biotechnology
CEO: Dr. David H. Kirn M.D.
Sector: Healthcare
Employees: 201
Address: 5858 Horton Street, EmeryVille, CA 94608
Phone: 510 505 2680
Last updated: 2024-12-31
Imunon, Inc.
GEN-1, Thermo Dox
Imunon, Inc. is a clinical stage biotechnology company specializing in the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies, focusing on products such as GEN-1 for ovarian cancer and Thermo Dox for various cancer indications.
About | Leadership | About | About | About | About | About | Leadership | Contact | Contact | About
Symbol: IMNN
Recent Price: $0.82
Industry: Biotechnology
CEO: Dr. Stacy R. Lindborg Ph.D.
Sector: Healthcare
Employees: 33
Address: 997 Lenox Drive, Lawrenceville, NJ 08648
Phone: 609 896 9100
Leadership
- Stacy R. Lindborg, PhD, President, Chief Executive Officer, and Board Director
- David Gaiero, Chief Financial Officer
- Khursheed Anwer, PhD, MBA, Executive Vice President and Chief Science Officer
- Kristin Longobardi, MBA, Senior Vice President, Strategic Operations
- Susan Eylward, General Counsel and Corporate Secretary
- Michael H. Tardugno,
- Frederick J. Fritz,
- Donald Braun, PhD,
- Christine Pellizzari, JD,
- James E. Dentzer,
Last updated: 2024-12-31
Immuneering Corporation
IMM-1-104 and IMM-6-415
Immuneering Corporation is a biopharmaceutical company focused on developing oncology and neuroscience product candidates, with key products like IMM-1-104 for cancer treatment and IMM-6-415 for solid tumors.
Symbol: IMRX
Recent Price: $2.25
Industry: Biotechnology
CEO: Dr. Benjamin J. Zeskind M.B.A., Ph.D.
Sector: Healthcare
Employees: 66
Address: 245 Main Street, Cambridge, MA 02142
Phone: 617 500 8080
Last updated: 2024-12-31
Iovance Biotherapeutics, Inc.
lifileucel
Iovance Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing and commercializing cancer immunotherapy products to utilize the immune system in eradicating cancer cells, with several ongoing phase 2 clinical studies.
Symbol: IOVA
Recent Price: $7.17
Industry: Biotechnology
CEO: Dr. Frederick G. Vogt Esq., J.D., Ph.D.
Sector: Healthcare
Employees: 557
Address: 825 Industrial Road, San Carlos, CA 94070
Phone: 650 260 7120
Last updated: 2024-12-31
Keros Therapeutics, Inc.
KER-050
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for hematological and musculoskeletal disorders. Their lead product candidate, KER-050, targets cytopenias, including anemia and thrombocytopenia.
About | Management | Directors | Contact | About | Contact | Careers | Benefits | Careers | About | Benefits | About | Careers | Jobs | Careers | Careers | Careers
Symbol: KROS
Recent Price: $15.64
Industry: Biotechnology
CEO: Dr. Jasbir S. Seehra Ph.D.
Sector: Healthcare
Employees: 149
Address: 99 Hayden Avenue, Lexington, MA 02421
Phone: 617 314 6297
Leadership
- Jasbir Seehra, Ph.D., Board Member
- Keith Regnante, M.B.A., Chief Financial Officer
- Christopher Rovaldi, President, Chief Operating Officer
- Esther Cho, J.D., Senior Vice President, General Counsel
- John Oram, M.B.A., Senior Vice President, Program and Portfolio Management
- Robin Wagner, Senior Vice President, Human Resources
- Carl L. Gordon, Ph.D., C.F.A., Board Member
- Jean-Jacques Bienaimé, M.B.A., Lead Independent Director
- Nima Farzan, M.B.A., Board Member
- Mary Ann Gray, Ph.D., Board Member
- Tomer Kariv, J.D., Board Member
- Julius Knowles, M.B.A., Board Member
- Ran Nussbaum, Board Member
- Alpna Seth, Ph.D., Board Member
Last updated: 2024-12-31
Leap Therapeutics, Inc.
DKN-01
Leap Therapeutics, Inc. is a biopharmaceutical company focused on acquiring and developing therapies for the treatment of cancer, with lead programs including DKN-01, targeting various cancer types through clinical trials.
Symbol: LPTX
Recent Price: $2.92
Industry: Biotechnology
CEO: Mr. Douglas E. Onsi J.D.
Sector: Healthcare
Employees: 54
Address: 47 Thorndike Street, Cambridge, MA 02141
Phone: 617 714 0360
Last updated: 2024-12-31
Nkarta, Inc.
NKX101 and NKX019
Nkarta, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing cell therapies for the treatment of cancer. The company specializes in cellular immunotherapy using chimeric antigen receptors on natural killer cells to target tumor antigens.
About | Contact | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Contact | Careers | About | Careers
Symbol: NKTX
Recent Price: $2.32
Industry: Biotechnology
CEO: Mr. Paul J. Hastings
Sector: Healthcare
Employees: 150
Address: 6000 Shoreline Court, South San Francisco, CA 94080
Phone: 415 582 4923
Last updated: 2024-12-31
PDS Biotechnology Corporation
PDS0101
PDS Biotechnology Corporation is a clinical-stage biopharmaceutical company focused on developing multifunctional cancer immunotherapies. Its lead product candidate, PDS0101, is in Phase II clinical trial for treating various human papillomavirus-associated malignancies.
Symbol: PDSB
Recent Price: $1.69
Industry: Biotechnology
CEO: Dr. Frank K. Bedu-Addo Ph.D.
Sector: Healthcare
Employees: 25
Address: 25B Vreeland Road, Florham Park, NJ 07932
Phone: 800 208 3343
Leadership
- Frank Bedu-Addo, Ph.D., Chief Executive Officer, Director
- Stephan Toutain, Chief Operating Officer
- Lars Boesgaard, Chief Financial Officer
- Gregory Conn, Ph.D., Chief Scientific Officer
- Kirk Shepard, M.D., Chief Medical Officer
- Spencer Brown, Senior Vice-President, General Counsel, Corporate Secretary and Compliance Officer
- Rory Cullinane, Vice President of Quality
- Joe Dervan, Ph.D., Vice President of Research and Development
- David Schaaf, M.D., Vice President of Medical Affairs
- Sir Richard Sykes, Director
- Ilian Iliev, Ph.D., Director
- Gregory Freitag, J.D., CPA, Director
- Otis W. Brawley, M.D., Director
- Kamil Ali-Jackson, J.D., Director
- Stephen Glover, Chairman
Last updated: 2024-12-31
Scopus BioPharma Inc.
Duet Platform
Scopus Bio Pharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics for serious diseases with lead programs in immuno-oncology gene therapy.
Symbol: SCPS
Recent Price: $0.00
Industry: Biotechnology
CEO: Dr. Alan D. Horsager Ph.D.
Sector: Healthcare
Employees: 13
Address: 420 Lexington Avenue, New York, NY 10170
Phone: 212 479 2513
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
Cullinan Oncology, Inc.
CLN-081
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. Their lead candidate, CLN-081, is in a trial for treating non-small cell lung cancer. The company also has several preclinical products targeting various forms of cancer.
Symbol: CGEM
Recent Price: $12.20
Industry: Biotechnology
CEO: Mr. Nadim Ahmed
Sector: Healthcare
Employees: 85
Address: One Main Street, Cambridge, MA 02142
Phone: 617 410 4650
Last updated: 2024-12-31
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31